Treatment of leukodystrophy

EP4766367A1Pending Publication Date: 2026-07-01THE PROVOST FELLOWS FOUNDATION SCHOLARS AND THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
THE PROVOST FELLOWS FOUNDATION SCHOLARS AND THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Filing Date
2024-10-04
Publication Date
2026-07-01

Smart Images

  • Figure EP2024077975_10042025_PF_FP_ABST
    Figure EP2024077975_10042025_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to the treatment of leukodystrophy. Specifically, the present invention relates to the treatment of leukodystrophies such as globoid cell leukodystrophy using acetylcholinesterase inhibitors such as donepezil. Also disclosed are methods of treatment of leukodystrophies such as globoid cell leukodystrophy and uses of acetylcholinesterase inhibitors such as donepezil in the treatment of leukodystrophies such as globoid cell leukodystrophy. Also disclosed is a method for diagnosing, detecting or identifying a leukodystrophy in a subject.
Need to check novelty before this filing date? Find Prior Art